These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34128348)

  • 1. Declines and pronounced regional disparities in meperidine use in the United States.
    Boyle JM; McCall KL; Nichols SD; Piper BJ
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00809. PubMed ID: 34128348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronounced Declines in Meperidine in the US: Is the End Imminent?
    Harrison LR; Arnet RE; Ramos AS; Chinga PA; Anthony TR; Boyle JM; McCall KL; Nichols SD; Piper BJ
    Pharmacy (Basel); 2022 Nov; 10(6):. PubMed ID: 36412830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rise and regional disparities in buprenorphine utilization in the United States.
    Pashmineh Azar AR; Cruz-Mullane A; Podd JC; Lam WS; Kaleem SH; Lockard LB; Mandel MR; Chung DY; Simoyan OM; Davis CS; Nichols SD; McCall KL; Piper BJ
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):708-715. PubMed ID: 32173955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions and pronounced regional differences in morphine distribution in the United States.
    Dowd ME; Tang EJ; Yan KT; McCall KL; Piper BJ
    Res Social Adm Pharm; 2023 Jun; 19(6):926-930. PubMed ID: 36894400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced Regional Disparities in United States Methadone Distribution.
    Furst JA; Mynarski NJ; McCall KL; Piper BJ
    Ann Pharmacother; 2022 Mar; 56(3):271-279. PubMed ID: 34184584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in medical use and abuse of opioid analgesics.
    Joranson DE; Ryan KM; Gilson AM; Dahl JL
    JAMA; 2000 Apr; 283(13):1710-4. PubMed ID: 10755497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Medical Use of Opioids in the U.S., 2006-2016.
    Piper BJ; Shah DT; Simoyan OM; McCall KL; Nichols SD
    Am J Prev Med; 2018 May; 54(5):652-660. PubMed ID: 29551331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meperidine: a critical review.
    Latta KS; Ginsberg B; Barkin RL
    Am J Ther; 2002; 9(1):53-68. PubMed ID: 11782820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016.
    Bosetti C; Santucci C; Radrezza S; Erthal J; Berterame S; Corli O
    Eur J Pain; 2019 Apr; 23(4):697-707. PubMed ID: 30407692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altering meperidine prescribing patterns in a university teaching hospital.
    Stevenson JG; Pearlman M; Green CR; Newland S; Grondin L; Thompson M; Golembiewski J; Campbell D
    Jt Comm J Qual Saf; 2004 May; 30(5):277-81, 233. PubMed ID: 15154319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
    Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
    Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis.
    Fisher JE; Zhang Y; Sketris I; Johnston G; Burge F
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):177-83. PubMed ID: 22081471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of meperidine prescribing in older adults: A longitudinal population-based study.
    Friesen KJ; Falk J; Bugden S
    BMC Geriatr; 2016 May; 16():100. PubMed ID: 27170170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declines and regional variation in opioid distribution by U.S. hospitals.
    Eidbo SA; Kropp Lopez AK; Hagedorn JD; Mathew V; Kaufman DE; Nichols SD; McCall KL; Piper BJ
    Pain; 2022 Jun; 163(6):1186-1192. PubMed ID: 34510133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradicating analgesic use of meperidine in a hospital.
    Raymo LL; Camejo M; Fudin J
    Am J Health Syst Pharm; 2007 Jun; 64(11):1148, 1150, 1152. PubMed ID: 17519454
    [No Abstract]   [Full Text] [Related]  

  • 17. Pronounced declines in dispensed licit fentanyl, but not fentanyl derivatives.
    Stemrich RA; Weber JV; McCall KL; Piper BJ
    Res Social Adm Pharm; 2022 Jun; 18(6):3046-3051. PubMed ID: 34419378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meperidine and the management of pain: what you need to know.
    Todd M
    Lippincotts Case Manag; 2004; 9(5):241-2. PubMed ID: 15540079
    [No Abstract]   [Full Text] [Related]  

  • 19. Meperidine utilization and compliance with Agency for Health Care Policy and Research guidelines in a tertiary care hospital.
    Pellegrini JE; Paice J; Faut-Callahan M
    CRNA; 1999 Nov; 10(4):174-80. PubMed ID: 10723296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meperidine: therapeutic use and toxicity.
    Clark RF; Wei EM; Anderson PO
    J Emerg Med; 1995; 13(6):797-802. PubMed ID: 8747629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.